Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Contact Activation Inhibition and Platelet Rich Plasma Are Required in Order to Differentiate Bleeders from Non-Bleeders in FXI Deficiency Using the Thrombin Generation Assay

Gillian N Pike, MBChB, MRCP, Anthony M Cumming, PhD FRCPath, Charles R.M Hay, MD FRCP, FRCPath, Jecko Thachil, MD MRCP, FRCPath, John Burthem, PhD FRCP, FRCPath, Paula H. B Bolton-Maggs, BMBCh, DM, FRCP, FRCPath

Blood (2014) 124 (21): 696.

https://doi.org/10.1182/blood.V124.21.696.696

Published: 2014

Journal Articles

Thrombin Generation and Bleeding in Hemophilia Inhibitor Patients during Immune Tolerance Induction

Margaret V. Ragni, MD MPH, Donna DiMichele, MD, Charles R.M. Hay, MD FRCP, FRCPath, Lynn M. Malec, MD, Craig D. Seaman, MD, Jonathan Yabes, PhD, Jie Li, MS, Saulius Butenas, PhD, Kathleen Brumel-Ziedins, PhD

Blood (2014) 124 (21): 1514.

https://doi.org/10.1182/blood.V124.21.1514.1514

Published: 2014

Journal Articles

Two Factor XI Concentrates Correct Impaired Thrombin Generation in Major FXI Deficiency but Are Not Equivalent in Their Effect

Gillian N Pike, MBChB, MRCP, Anthony M Cumming, PhD FRCPath, Charles R.M Hay, MD FRCP, FRCPath, Brenda Sempasa, Bsc, Mphil, Megan Sutherland, PhD, Jecko Thachil, MD MRCP, FRCPath, John Burthem, PhD FRCP, FRCPath, Paula H. B Bolton-Maggs, BMBCh, DM, FRCP, FRCPath

Blood (2014) 124 (21): 1519.

https://doi.org/10.1182/blood.V124.21.1519.1519

Published: 2014

Journal Articles

Human-Cl Rhfviii Effectively and Safely Prevents Bleeding Episodes in Previously Treated Adult Patients with Severe Haemophilia A

Sigurd Knaub, PhD, Toshko Lissitchkov, MD, PhD, Kingsley Hampton, Mario Von Depka, Savita Rangarajan, MBBS, FRCP, FRCPath, Charles R.M. Hay, MD, FRCP, FRCPath, Edward GD Tuddenham, MBBS, FRCP, FRCPath, PhD, Peter Collins, MD, Katharina Holstein, MD, Angela Huth-Kühne, Ingrid Pabinger, MD, Johannes Oldenburg, MD, Johann Bichler

Blood (2012) 120 (21): 1132.

https://doi.org/10.1182/blood.V120.21.1132.1132

Published: 2012

Journal Articles

Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom

Charles R.M. Hay, Ben Palmer, Elizabeth Chalmers, Ri Liesner, Rhona Maclean, Savita Rangarajan, Michael Williams, Peter W. Collins, on behalf of United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO)

Blood (2011) 117 (23): 6367–6370.

https://doi.org/10.1182/blood-2010-09-308668

Published: 2011

Journal Articles

Rituximab for Treatment of Resistant Inhibitors in Severe Haemophilia a: A Consecutive National Cohort.

Raina Liesner, MA, MBBChir, MD, MRCP, MRCPCH.F, Mary Mathias, BA, MBBS, MRCP, FRCPath, John Hanley, Russell Keenan, PhD, David M. Keeling, MD, Michael Laffan, Elizabeth Chalmers, Charles R.M. Hay, MD, FRCP, FRCPath, Rhona Maclean, Savita Rangarajan, MBBS, FRCP, FRCPath, Mike Williams, David J. Perry, MD, PhD, FRCP, FRCPath, Peter Collins

Blood (2008) 112 (11): 2275.

https://doi.org/10.1182/blood.V112.11.2275.2275

Published: 2008

NARROW

Contact Activation Inhibition and Platelet Rich Plasma Are Required in Order to Differentiate Bleeders from Non-Bleeders in FXI Deficiency Using the Thrombin Generation Assay

Thrombin Generation and Bleeding in Hemophilia Inhibitor Patients during Immune Tolerance Induction

Two Factor XI Concentrates Correct Impaired Thrombin Generation in Major FXI Deficiency but Are Not Equivalent in Their Effect

Human-Cl Rhfviii Effectively and Safely Prevents Bleeding Episodes in Previously Treated Adult Patients with Severe Haemophilia A

Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom

Rituximab for Treatment of Resistant Inhibitors in Severe Haemophilia a: A Consecutive National Cohort.

Email alerts

ASH Publications

American Society of Hematology

Contact Activation Inhibition and Platelet Rich Plasma Are Required in Order to Differentiate Bleeders from Non-Bleeders in FXI Deficiency Using the Thrombin Generation Assay

Thrombin Generation and Bleeding in Hemophilia Inhibitor Patients during Immune Tolerance Induction

Two Factor XI Concentrates Correct Impaired Thrombin Generation in Major FXI Deficiency but Are Not Equivalent in Their Effect

Human-Cl Rhfviii Effectively and Safely Prevents Bleeding Episodes in Previously Treated Adult Patients with Severe Haemophilia A

Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom

Rituximab for Treatment of Resistant Inhibitors in Severe Haemophilia a: A Consecutive National Cohort.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only